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1. Introduction 
The structural variability between the two known 
relaxin sequences from the pig [l-3] and rat [4] far 
exceed that observed for any insulin pair, yet their pri- 
mary sequences can readily be folded into an insulin 
conformation [ 561. This raises the question of how 
much more variability in the primary sequence may 
be tolerated without preventing an insulin-like folding 
to occur and how much of the surface may be varied 
without loss of receptor interaction. The evolutionary 
diversion of relaxins from each other and the possible 
existence of a common ancestral gene for relaxins and 
insulinsled us to examine the structure of shark relaxin. 
Based on the assumption that sharks have existed in 
their present form for at least 500 million years, i.e., 
have lived close to the point at which fishes and the 
ancestors of mammals are assumed to have branched 
from each other and where the insulin gene might have 
undergone duplication to give rise to the relaxin gene, 
we expected to observe a closer relation between the 
relaxin of this quasi-prehistoric species and insulins. 
2. Materials and methods 
Ovaries from the sand tiger shark (Odontaspis tau- 
rus) were obtained with the help of the Charleston 
Shark Fishing Club. The ovaries were removed from 
pregnant animals (pup size from 8-10 in.) and imme- 
diately placed on ice. The extraction of relaxin was 
performed as in [ 71 and relaxin fractions were iden- 
tified by the bioassay in guinea pigs [ 81. The primary 
structure analysis was performed on a Beckmann 
809TC automatic sequencer using a 0.1 M quadrol 
program no. 122974 and polybrene to aid retention 
of peptides in the sequencer cup. PTH residues were 
identified by high-performance liquid chromatography 
(HPLC) using a Waters liquid chromatograph system 
by the procedure in [9]. 
Shark relaxin was reduced and alkylated with iodo- 
[ 3H] acetic acid in 6 M guanidlne-HCl. The chains 
were subsequently separated by HPLC as in [7]. 
For real-time display of relaxin models the Evans 
and Sutherland picture system II was employed. We 
have used the computer program FRODO [lo] that 
was extensively modified and recoded for the Evans 
and Sutherland picture system by T. A. Jones and 
I. J. Tickle. The mainchain and disulphide conforma- 
tions were assumed to be identical with those of insu- 
lin [12]. 
3. Results and discussion 
The complete sequence of the A chain of the shark 
relaxin was obtained by automatic sequencing of 
-20 nmol material. Sequential yields remained as high 
as 85-90% up to the last 3 residues when the yield 
dropped as expected. However, no ambiguities arose 
and the sequence was confirmed by amino acid anal- 
ysis and automatic sequence analysis of tryptic pep- 
tides obtained from a second sample of the A chain. 
The B chain was much more difficult to obtain in 
pure form at reasonable yields than that of porcine 
relaxin. The N-terminus was blocked by a PCA residue 
that could not be removed from the whole chain 
because of solubility problems. The PCA peptide was 
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later lost after trypsin digestion as was a possible exten- 
sion of the B chain beyond Arg 23. The remaining 
peptides Leu-Cys-Gly-Arg,Gly-Phe-Ileu-Arg and 
Ala-Ileu-Ileu-Phe-Ala-Cys-Gly-Gly-Ser-Arg 
were isolated by HPLC and the primary sequence 
determined by automatic sequence analysis. The pep- 
tides were ordered by analogy to obtained sequences. 
The primary structure of the core of shark relaxin is 
displayed in fig.1 together with the sequences of rat 
and pig relaxin. Because of the seasonal migration of 
Odontaspis taurus the additional ovarian tissue 
required to complete the analysis of the shark relaxin 
will not be available for several months. The portion 
of the structure presented is that which is primarily 
responsible for the folding of the molecule and thus 
of greatest interest. Blocks of homology extending 
over all 3 chains are indicated in fig.1. Invariant posi- 
tions are by and large occupied by amino acids that 
are important for chain folding and crosslinking. All 
residues forming the hydrophobic core in insulin are 
also hydrophobic in the relaxins and all cysteines are 
invariant as are the glycines at B8 and B20 which 
allow a main chain conformation similar to that of 
insulin as shown in stereo view in fig.2. One of the 
more surprising aspects is the existence of Bl 1 Phe 
and B12.Ileu which are Leu and Val, respectively, in 
porcine relaxin as well as in all insulins. This part of 
the structure is shown in fig.3. Similar changes occur 
in rat relaxins 6here Bl 1 and B12 are tyrosine and 
alanine, respectively. In fact the Bl 1 can be accom- 
modated as an aromatic residue by allowing the side- 
chain to point into the region occupied by tryptophan Fig.2. Stereo view of shark relaxin. 
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Fig.3. Surface residues of shark relaxin viewed at right angles 
to the axis of the A chain N-terminal helix. 
in porcine relaxin. Perhaps the rat relaxin sequence is 
most surprising in this respect in having aromatic resi- 
dues at both positions, Bl 1 and B15. It is interesting 
that in shark relaxin B6 Leu and B14 Ala are identical 
to most insulin sequences. The ion pairs observed in 
porcine relaxin [5] are conserved in shark relaxin at 
A5 Lys and Al 5 Asp only and in rat relaxin at B13 
Arg and B17 Glu only. 
Our studies of relaxin structures suggest that there 
exists a stringent requirement to maintain the tertiary 
structure in spite of the total absence of common 
immunological determinants and active sites. The 
maintenance of the three-dimensional structure pro- 
vides an interesting contrast to the maintenance of 
active site configuration as exemplified by the differ- 
ences between subtilisin and mammalian serine prote- 
ases of the trypsin family [ 111. 
Because of the variability of the primary structure 
of relaxin it is difficult if not impossible to predict 
which of the relaxin surfaces are important for bio- 
activity. However, we note with interest the conserva- 
tion of positivelycharged residues, arginines or lysines, 
at positions B9, B13, A13 and A14. While it was sug- 
gested by us that the Trp B15 was important for relaxin 
activity we note that shark relaxin does not possess 
this residue. Shark relaxin is not active in mice but 
.fully active in guinea pigs suggesting that variability 
of the relaxin surfaces (Trp B15, for example), might 
be tolerable because of receptor variability far beyond 
that observed for insulin receptors. The selective force 
for the evolution of biomolecules is a function which 
appears to depend, in the case of relaxin, on the three- 
dimensional projection of the various protein folds. If 
the prediction of highly variable receptors for relaxin 
is incorrect, then the next 2 or 3 sequences of relaxins 
from different species should allow us to outline the 
various sites of interaction with antibodies and recep- 
tors as it has been done successfully for insulin. 
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